Gene Therapy Market Size, Share & Trends Analysis Report 2024-2030, By Indication, By Vector Type, By Route Of Administration, By Region and Segment Forecasts
20 août 2024 06h28 HE
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type...
Genome Editing Technologies Market Report 2024-2034 - Emerging Economies Projected to Boost Industry Growth
27 juin 2024 07h20 HE
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Genome Editing Technologies Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Genome Editing...
Global Recombinant Proteins Industry Research 2023-2024 & 2029: Increasing Demand for Non-Hybridoma Techniques, Diagnostic and Therapeutic Applications of Recombinant Antibodies
27 juin 2024 04h23 HE
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Recombinant Proteins Market" report has been added to ResearchAndMarkets.com's offering.The global market for recombinant proteins is estimated...
Global Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), Delivery Method (Ex-vivo, In-vivo) 2024-2030
18 juin 2024 10h19 HE
|
Research and Markets
Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "Global Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), Delivery Method (Ex-vivo, In-vivo),...
Global Gene Editing Tools Market Report 2024: A $3.83 Billion Market by 2034, with a CAGR of 18.84% During 2024-2034
27 mai 2024 04h13 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Global Gene Editing Tools Market" report has been added to ResearchAndMarkets.com's offering.The global gene editing tools market accounted for USD...
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
15 avr. 2024 09h00 HE
|
Caribou Biosciences, Inc.
BERKELEY, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced an abstract...
SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers
01 avr. 2024 09h30 HE
|
SOHM, Inc.
CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs...
NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant
11 mars 2024 08h15 HE
|
Napigen, Inc.
The USPTO issued a patent to NAPIGEN for the use of CRISPR technologies to edit organellar genomes. Separately, USDA awarded NAPIGEN an SBIR phase 1 grant.
Global Genome Editing Market to Reach US$ 26.5 Billion by 2034 at a CAGR of 15.7%: A Revolution in Biomedicine | Future Market Insights Inc.
27 févr. 2024 13h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The genome editing market is predicted to reach US$ 6.2 billion by 2024. The market size is expected to reach US$ 26.5 billion by 2034, projected at a...
Genome Editing Market Size & Share to Surpass USD 17.5 billion by 2031, Exhibiting a CAGR of 13.9% | States Transparency Market Research, Inc.
12 févr. 2024 09h33 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global genome editing market was projected to attain US$ 5.5 billion in 2022. It is...